Is 2-Hydroxypropyl-β-cyclodextrin a Suitable Carrier for Central Administration of Δ9-Tetrahydrocannabinol? Preclinical Evidence.

MLA

Agabio, R., et al. “Is 2-Hydroxypropyl-β-Cyclodextrin a Suitable Carrier for Central Administration of Δ9-Tetrahydrocannabinol? Preclinical Evidence.” Drug Development Research, vol. 78, no. 8, Dec. 2017, pp. 411–19. EBSCOhost, https://doi.org/10.1002/ddr.21413.

APA

Agabio, R., Sanna, F., Lobina, C., Monduzzi, M., Nairi, V., Cugia, F., Mameli, S., Pisanu, G. M., Gessa, G. L., & Melis, M. R. (2017). Is 2-Hydroxypropyl-β-cyclodextrin a Suitable Carrier for Central Administration of Δ9-Tetrahydrocannabinol? Preclinical Evidence. Drug Development Research, 78(8), 411–419. https://doi.org/10.1002/ddr.21413

Chicago

Agabio, R., F. Sanna, C. Lobina, M. Monduzzi, V. Nairi, F. Cugia, S. Mameli, G. M. Pisanu, G. L. Gessa, and M. R. Melis. 2017. “Is 2-Hydroxypropyl-β-Cyclodextrin a Suitable Carrier for Central Administration of Δ9-Tetrahydrocannabinol? Preclinical Evidence.” Drug Development Research 78 (8): 411–19. doi:10.1002/ddr.21413.